Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer

Published:2011-03-01 Issue:1 Volume:6 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Roeder Falk,Zwicker Felix,Saleh-Ebrahimi Ladan,Timke Carmen,Thieke Christian,Bischof Marc,Debus Juergen,Huber Peter E

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-6-22.pdf

Reference41 articles.

1. Chua DT, Sham JS, Kwong DL, Au GK: Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer 2003, 98: 74-80. 10.1002/cncr.11485

2. Xiao WW, Han F, Lu TX, Chen CY, Huang Y, Zhao C: Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009, 74: 1070-1076. 10.1016/j.ijrobp.2008.09.008

3. Al-Sarraf M, Leblanc M, Giri PG, Fu KK, Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE, Ensley JF: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase II randomized intergroup study 0099. J Clin Oncol 1998, 16: 1310-1317.

4. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, Chua ET, Yang E, Lee KM, Fong KW, Tan HS, Lee KS, Loong S, Sethi V, Chua EJ, Machin D: Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005, 23: 6730-6738. 10.1200/JCO.2005.16.790

5. Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL, Guo Y, Lin AH, Zeng XF, Ma J: Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 2008, 71: 1356-1364. 10.1016/j.ijrobp.2007.12.028

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal treatment according to the NPC‐GPOH trials in adult patients with nasopharyngeal cancer—Analysis based on a single‐center experience;Cancer Reports;2024-08

2. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose–volume–outcome analysis;European Archives of Oto-Rhino-Laryngology;2023-11-23

3. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria;International Journal of Radiation Oncology*Biology*Physics;2022-07

4. Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis;Head & Neck;2021-08-17

5. Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery;Cancer Letters;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3